Mark Swain
6PUBLICATIONS
66CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 12, 2025
A review of multidisciplinary care in metabolic dysfunction-associated steatohepatitis and cardiometabolic disease, with a focus on Canada.James Kim, Paolo Raggi, Anne-Marie Carreau
|Mar 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?David E J Jones, Ulrich Beuers, Alan Bonder
|Oct 31, 2023
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.Marlyn J Mayo, John M Vierling, Christopher L Bowlus
|Jun 30, 2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.Gideon M Hirschfield, Mitchell L Shiffman, Aliya Gulamhusein
|Feb 22, 2023
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial.David Jones, Marco Carbone, Pietro Invernizzi
|Feb 15, 2023
Impact of depression and antidepressant use on clinical outcomes of hepatitis B and C: a population-based study.Abdel Aziz Shaheen, Gilaad G Kaplan, Keith A Sharkey
Pageof 1
Frequent Collaborators
4 joint publications
Cynthia Levy
3 joint publications
Palak Trivedi
3 joint publications
Marlyn Mayo
3 joint publications
Gideon M Hirschfield
2 joint publications
John M Vierling
2 joint publications
Stuart C Gordon
2 joint publications
David Jones
2 joint publications
Marco Carbone
2 joint publications
Pietro Invernizzi
2 joint publications
Frederik Nevens
